Medicine
-

NIH Releases New Strategic Plan for Dietary Supplements
Read more: NIH Releases New Strategic Plan for Dietary SupplementsNIH’s new supplement plan prioritizes research on diverse populations and public health needs.
-

Fall 2025 Supplement Trends Focus on Immunity and Personalization
Read more: Fall 2025 Supplement Trends Focus on Immunity and Personalization2025 supplement trends highlight immunity, mood, gut health, and personalized formulations.
-

AI Predicts Disease from DNA Mutations
Read more: AI Predicts Disease from DNA MutationsAI breakthrough enables precise disease prediction from genetic mutations, paving the way for personalized medicine.
-

AI Model Predicts Kidney Disease with 99% Accuracy in High-Risk Indian Region
Read more: AI Model Predicts Kidney Disease with 99% Accuracy in High-Risk Indian RegionA custom AI model accurately predicts chronic kidney disease in India’s Uddanam region, offering hope for timely interventions in high-risk populations.
-

AI-Driven Tool Qualified by U.S. FDA to Speed Liver Disease Drug Development
Read more: AI-Driven Tool Qualified by U.S. FDA to Speed Liver Disease Drug DevelopmentThe FDA has qualified AIM-NASH, an AI tool that automates liver pathology assessments to speed up drug development for liver disease, potentially transforming clinical research efficiency.
-

FDA Approves First Precision Therapy for Aggressive BRCA2-Mutated Prostate Cancer
Read more: FDA Approves First Precision Therapy for Aggressive BRCA2-Mutated Prostate CancerA new FDA-approved dual-action pill targeting BRCA2 mutations significantly cuts prostate cancer progression risk by 54%.
-

Hydrogen Sulfide Shows Promise as a Safer Treatment for Stubborn Nail Fungus
Read more: Hydrogen Sulfide Shows Promise as a Safer Treatment for Stubborn Nail FungusA new study suggests hydrogen sulfide may effectively treat fungal nail infections without the systemic risks associated with current oral medications, offering a potentially safer and more targeted alternative for a widespread and persistent health problem.
-

Stem Cell Therapy for Alzheimer’s Disease Advances to Phase 2 Trials
Read more: Stem Cell Therapy for Alzheimer’s Disease Advances to Phase 2 TrialsA patient-derived stem cell therapy for Alzheimer’s moves to Phase 2 trials after showing potential to slow cognitive decline.
-

Qubits and Healthcare: Quantum Computing Has Arrived in Cleveland 11.21.2025
Read more: Qubits and Healthcare: Quantum Computing Has Arrived in Cleveland 11.21.2025Quantum Computing has arrived in Cleveland to work on healthcare.

